Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856414 · ClinicalTrials.gov registry record · Phase 4
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
A Phase 4 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00856414 is a Phase 4 study that has completed, run by Allergan. The registered enrollment target is 45 participants.
The verdict
NCT00856414, a Phase 4 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)
Interventions
- BIOLOGICAL botulinum toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856414
The ClinicalTrials.gov registry entry for NCT00856414 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which botulinum toxin Type A is the first listed.
NCT00856414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856414 about?
NCT00856414 is a clinical study titled "Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines". This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)
What is the current status of trial NCT00856414?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2009-03. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00856414?
The interventions under investigation include: botulinum toxin Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT00856414?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.